Manufacturers should brace for a renewed outcry on drug prices later this year as more members of commercial insurance plans feel the effects of a change in benefit design that is intended to discourage the use of copay coupons for specialty drugs.
A growing number of payers are implementing policies known as copay "accumulators" that closely track the use of coupons so...